| Review Article Online Published: 27 Aug 2026 | ||||||||||||
Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review Naif Awadh Alghamdi, Abdullah Alsalamah, Rayan Alsofyan, Sami Alshammari.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Alghamdi NA, Alsalamah A, Alsofyan R, Alshammari S. Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review. IJMDC. Online First: 27 Aug, 2026. doi:10.24911/IJMDC.51-1783753724 Web Style Alghamdi NA, Alsalamah A, Alsofyan R, Alshammari S. Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review. https://www.ijmdc.com/?mno=327430 [Access: August 28, 2026]. doi:10.24911/IJMDC.51-1783753724 AMA (American Medical Association) Style Alghamdi NA, Alsalamah A, Alsofyan R, Alshammari S. Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review. IJMDC. Online First: 27 Aug, 2026. doi:10.24911/IJMDC.51-1783753724 Vancouver/ICMJE Style Alghamdi NA, Alsalamah A, Alsofyan R, Alshammari S. Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review. IJMDC, [cited August 28, 2026]; Online First: 27 Aug, 2026. doi:10.24911/IJMDC.51-1783753724 Harvard Style Alghamdi, N. A., Alsalamah, . A., Alsofyan, . R. & Alshammari, . S. (2026) Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review. IJMDC, Online First: 27 Aug, 2026. doi:10.24911/IJMDC.51-1783753724 Turabian Style Alghamdi, Naif Awadh, Abdullah Alsalamah, Rayan Alsofyan, and Sami Alshammari. 2026. Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review. International Journal of Medicine in Developing Countries, Online First: 27 Aug, 2026. doi:10.24911/IJMDC.51-1783753724 Chicago Style Alghamdi, Naif Awadh, Abdullah Alsalamah, Rayan Alsofyan, and Sami Alshammari. "Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review." International Journal of Medicine in Developing Countries Online First: 27 Aug, 2026. doi:10.24911/IJMDC.51-1783753724 MLA (The Modern Language Association) Style Alghamdi, Naif Awadh, Abdullah Alsalamah, Rayan Alsofyan, and Sami Alshammari. "Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review." International Journal of Medicine in Developing Countries Online First: 27 Aug, 2026. Web. 28 Aug 2026 doi:10.24911/IJMDC.51-1783753724 APA (American Psychological Association) Style Alghamdi, N. A., Alsalamah, . A., Alsofyan, . R. & Alshammari, . S. (2026) Safety and efficacy of continuous terlipressin infusion in hepatorenal syndrome–acute kidney injury: a systematic review. International Journal of Medicine in Developing Countries, Online First: 27 Aug, 2026. doi:10.24911/IJMDC.51-1783753724 |